Han Kiat Ho

430 total citations
7 papers, 352 citations indexed

About

Han Kiat Ho is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Han Kiat Ho has authored 7 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Nephrology. Recurrent topics in Han Kiat Ho's work include Fibroblast Growth Factor Research (3 papers), Kruppel-like factors research (3 papers) and Epigenetics and DNA Methylation (2 papers). Han Kiat Ho is often cited by papers focused on Fibroblast Growth Factor Research (3 papers), Kruppel-like factors research (3 papers) and Epigenetics and DNA Methylation (2 papers). Han Kiat Ho collaborates with scholars based in Singapore, United States and Germany. Han Kiat Ho's co-authors include Stefan Hart, Jens E. Ruhe, Seng Gee Lim, Axel Ullrich, Sylvia Streit, Hooi Linn Loo, Sharon Pok, Myat Oo Aung, Kah Suan Lim and Tse Siang Kang and has published in prestigious journals such as Oncogene, Journal of Hepatology and Biochemical Pharmacology.

In The Last Decade

Han Kiat Ho

7 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Kiat Ho Singapore	7	278	51	40	33	31	7	352
Changjin Chen United States	7	229 0.8×	70 1.4×	40 1.0×	15 0.5×	16 0.5×	9	345
Mandar Deodhar Australia	8	233 0.8×	21 0.4×	46 1.1×	56 1.7×	15 0.5×	14	369
Chuanzhong Mei China	10	263 0.9×	111 2.2×	46 1.1×	38 1.2×	10 0.3×	15	387
Ahmed Gaafar Ahmed Gaafar Egypt	9	129 0.5×	22 0.4×	44 1.1×	18 0.5×	24 0.8×	16	263
Keiichiro Hiramoto Japan	6	318 1.1×	36 0.7×	37 0.9×	8 0.2×	19 0.6×	15	434
Xuanming Pan China	6	246 0.9×	123 2.4×	35 0.9×	23 0.7×	19 0.6×	7	362
Manali Dimri United States	6	227 0.8×	107 2.1×	55 1.4×	41 1.2×	69 2.2×	10	401
Jingyang He China	11	222 0.8×	59 1.2×	55 1.4×	14 0.4×	11 0.4×	21	324
Chin‐Wen Chi Taiwan	9	179 0.6×	75 1.5×	87 2.2×	39 1.2×	21 0.7×	11	372

Countries citing papers authored by Han Kiat Ho

Since Specialization

Citations

This map shows the geographic impact of Han Kiat Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Kiat Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Kiat Ho more than expected).

Fields of papers citing papers by Han Kiat Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Kiat Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Kiat Ho. The network helps show where Han Kiat Ho may publish in the future.

Co-authorship network of co-authors of Han Kiat Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Han Kiat Ho. A scholar is included among the top collaborators of Han Kiat Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Kiat Ho. Han Kiat Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ho, Han Kiat, et al.. (2013). Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. Drug Discovery Today. 19(1). 51–62. 54 indexed citations

2.

Saha, Sudipta, Winnie Wong, Lee Sun New, et al.. (2012). Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties. European Journal of Pharmacology. 697(1-3). 13–23. 29 indexed citations

3.

Roidl, Andreas, Willy Wong, S. Streit, et al.. (2009). The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene. 29(10). 1543–1552. 46 indexed citations

4.

Ho, Han Kiat, Sharon Pok, Sylvia Streit, et al.. (2008). Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of Hepatology. 50(1). 118–127. 154 indexed citations

5.

Ho, Han Kiat, Yankai Jia, Kevin J. Coe, et al.. (2006). Cytosolic heat shock proteins and heme oxygenase-1 are preferentially induced in response to specific and localized intramitochondrial damage by tetrafluoroethylcysteine. Biochemical Pharmacology. 72(1). 80–90. 10 indexed citations

6.

Ho, Han Kiat, Collin C. White, Carolina Fernández, et al.. (2005). Nrf2 Activation Involves an Oxidative-Stress Independent Pathway in Tetrafluoroethylcysteine-Induced Cytotoxicity. Toxicological Sciences. 86(2). 354–364. 47 indexed citations

7.

Ho, Han Kiat, Shie-Pon Tzung, David M. Hockenbery, et al.. (2004). BCL-xL overexpression effectively protects against tetrafluoroethylcysteine-induced intramitochondrial damage and cell death. Biochemical Pharmacology. 69(1). 147–157. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact